LIFE DRY EYE TEARS- glycerin, hypromellose solution

দেশ: মার্কিন যুক্তরাষ্ট্র

ভাষা: ইংরেজি

সূত্র: NLM (National Library of Medicine)

সক্রিয় উপাদান:

HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) (HYPROMELLOSE, UNSPECIFIED - UNII:3NXW29V3WO), GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX)

থেকে পাওয়া:

KC Pharmaceuticals, Inc.

প্রশাসন রুট:

OPHTHALMIC

প্রেসক্রিপশন টাইপ:

OTC DRUG

অনুমোদন অবস্থা:

Export only

পণ্য বৈশিষ্ট্য

LIFE DRY EYE TEARS- GLYCERIN, HYPROMELLOSE SOLUTION
KC PHARMACEUTICALS, INC.
----------
LIFE DRY EYE TEARS (MFR - EXPORT)
LIFE DRY EYE TEARS
LIFE DRY EYE TEARS
glycerin, hypromellose solution
PRODUCT INFORMATION
PRODUCT TYPE
HUMAN OTC DRUG
ITEM CODE (SOURCE)
NDC:55651-016
ROUTE OF ADMINISTRATION
OPHTHALMIC
ACTIVE INGREDIENT/ACTIVE MOIETY
INGREDIENT NAME
BASIS OF STRENGTH STRENGTH
HYPROMELLOSE, UNSPECIFIED (UNII: 3NXW29V3WO) (HYPROMELLOSE,
UNSPECIFIED - UNII:3NXW29V3WO)
HYPROMELLOSE,
UNSPECIFIED
0.2 g
in 100 mL
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX)
GLYCERIN
0.2 g
in 100 mL
INACTIVE INGREDIENTS
INGREDIENT NAME
STRENGTH
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)
WATER (UNII: 059QF0KO0R)
EDETATE DISODIUM (UNII: 7FLD91C86K)
SODIUM CHLORIDE (UNII: 451W47IQ8X)
SODIUM CITRATE (UNII: 1Q73Q2JULR)
DEXTROSE (UNII: IY9XDZ35W2)
POLYETHYLENE GLYCOL, UNSPECIFIED (UNII: 3WJQ0SDW1A)
POTASSIUM CHLORIDE (UNII: 660YQ98I10)
SODIUM BICARBONATE (UNII: 8MDF5V39QO)
SODIUM PHOSPHATE, DIBASIC (UNII: GR686LBA74)
SODIUM PHOSPHATE, MONOBASIC (UNII: 3980JIH2SW)
PACKAGING
# ITEM CODE
PACKAGE DESCRIPTION
MARKETING START
DATE
MARKETING END
DATE
1
NDC:55651-
016-01
1 in 1 CARTON
03/20/2023
1
15 mL in 1 BOTTLE, DROPPER; Type 0: Not a
Combination Product
MARKETING INFORMATION
MARKETING
CATEGORY
APPLICATION NUMBER OR MONOGRAPH
CITATION
MARKETING START
DATE
MARKETING END
DATE
Export only
03/20/2023
LABELER -
KC Pharmaceuticals, Inc. (174450460)
ESTABLISHMENT
NAME
ADDRESS
ID/FEI
BUSINESS OPERATIONS
K.C. Pharmaceuticals, Inc.
174450460
manufacture(55651-016) , pack(55651-016) , label(55651-016)
KC Pharmaceuticals, Inc.
Revised: 3/2023